ArticleLaryngoscope investigative otolaryngology2025
Changes in Thyroglossal Duct Cyst Case Volume During the COVID-19 Pandemic.
Article in Laryngoscope investigative otolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Changes in Thyroglossal Duct Cyst Case Volume During the COVID-19 Pandemic.Laryngoscope investigative otolaryngology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Objective: The purpose of this study is to identify trends in thyroglossal duct cyst (TGDC) presentation, management, and clinical characteristics in patients before and after the COVID-19 pandemic. Methods: A retrospective chart review was conducted at a tertiary referral center and community hospital. Patients were identified using TGDC diagnosis and surgical codes and organized into two cohorts: "Pre-COVID" (May 18th, 2016-March 10th, 2020) and "COVID" (March 11th, 2020-December 31st, 2023). Patient demographics, clinical characteristics, and surgical rates and outcomes were obtained. Results: The case volume of patients presenting with TGDCs did not differ significantly between pre-COVID ( Conclusion: The presentation or surgical rates of patients presenting with TGDC in the pre-COVID vs. COVID periods did not significantly change. However, COVID patients were more likely to present with an infected mass or sequelae of infection, suggesting delays in seeking care until infection occurred or greater infection rates in these cysts. Future studies with larger sample sizes may help clarify trends in TGDC case volume before and after the COVID-19 pandemic, explaining variances in referral and presentation patterns. Level of Evidence: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.